Kallikrein 9 anticorps (AA 239-250)
Aperçu rapide pour Kallikrein 9 anticorps (AA 239-250) (ABIN289486)
Antigène
Voir toutes Kallikrein 9 (KLK9) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 239-250
-
Purification
- Affinity chromatography purified
-
Immunogène
- KLK-L3 antibody was raised in rabbit using AA 239-250 [HYLDWIQEIMEN] of the human KLK-L3 (KLK9) protein as the immunogen.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- Kallikrein 9 (KLK9)
-
Autre désignation
- KLK-L3
-
Sujet
- Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. (KLK-L3, HGMW-approved symbol KLK9) is a novel kallikrein gene with utility for diagnosis, monitoring and therapeutics of various cancers including those of the breast, prostate and testis.
-
Pathways
- Système du Complément
Antigène
-